KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Net Income: 2010-2025

Historic Net Income for Dynavax Technologies (DVAX) over the last 16 years, with Sep 2025 value amounting to $26.9 million.

  • Dynavax Technologies' Net Income rose 53.05% to $26.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$43.4 million, marking a year-over-year decrease of 311.57%. This contributed to the annual value of $27.3 million for FY2024, which is 527.44% up from last year.
  • According to the latest figures from Q3 2025, Dynavax Technologies' Net Income is $26.9 million, which was up 43.83% from $18.7 million recorded in Q2 2025.
  • Dynavax Technologies' Net Income's 5-year high stood at $128.8 million during Q2 2022, with a 5-year trough of -$96.1 million in Q1 2025.
  • For the 3-year period, Dynavax Technologies' Net Income averaged around -$2.7 million, with its median value being $7.0 million (2024).
  • Per our database at Business Quant, Dynavax Technologies' Net Income soared by 14,350.62% in 2022 and then crashed by 1,004.69% in 2025.
  • Quarterly analysis of 5 years shows Dynavax Technologies' Net Income stood at $99.8 million in 2021, then plummeted by 32.12% to $67.7 million in 2022, then crashed by 99.68% to $219,000 in 2023, then spiked by 3,119.18% to $7.0 million in 2024, then surged by 53.05% to $26.9 million in 2025.
  • Its Net Income stands at $26.9 million for Q3 2025, versus $18.7 million for Q2 2025 and -$96.1 million for Q1 2025.